People taking Eli Lilly and Co.'s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the medications.

Proposed roster caps have prevented U.S. District Judge Claudia Wilken from approving a $2.78 billion settlement, which is ...

The proposal, expected to be announced by President Trump on Monday, will face fierce opposition from the pharmaceutical ...

The Ignite lost a four-game battle to the Orlando Valkyries on Sunday in the Pro Volleyball Federation's title match ...

The Indy Ignite professional volleyball team—which is in its first year of competition—will play Sunday for the Pro ...

The deal follows concerns raised during the 2025 legislative session over proposed budget language that could have stripped ...

Arizona, reintroduced legislation to jumpstart the country's "rusted" shipbuilding industry and increase onshore ship ...

Welcome to Fast 25, IBJ’s annual ranking of the fastest-growing companies in the Indianapolis area. Plus this year’s winner ...

Geng Wang has volunteered for much of his life. Now a company he started helps organizations provide services to others. Wang ...

Rob Mathews, executive director of Ball State University’s Entrepreneurship Center, views leadership and innovation as ...

The extended partnership holds the potential to be the largest industry-academic agreement of its kind in the United States, ...

Representatives from Eli Lilly, Cook Medical and other Hoosier businesses gave advice about tariffs during the Indiana ...